• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肾上腺皮质癌。临床、病理及治疗研究]

[Adrenal gland carcinoma. Clinical, pathologic, and therapeutic study].

作者信息

Osca García J M, Beamud Gómez A, Ruíz Cerda J, Jabaloyas J M, Morera Martínez J, Jiménez Cruz J F

机构信息

Servicio de Urología, Hospital La Fe, Valencia, España.

出版信息

Arch Esp Urol. 1994 Jul-Aug;47(6):557-62.

PMID:7944596
Abstract

From 1973 to 1991, 13 patients [4 females (30%) and 9 males (70%)] were diagnosed with adrenal carcinoma at our hospital. The mean age at the time of diagnosis was 47.4 years (range 29 to 72 yrs). Eleven patients (85%) presented with abdominal symptoms and 8 (61%) with paraneoplastic syndrome. At the time of diagnosis, 3 (23%) had clinical or radiological signs of metastasis. Five patients (38.5%) had regional involvement and 5 (38.5%) had localized disease. The preoperative imaging studies disclosed an abnormal IVP in 8 of 13 patients (61%); 7 of 10 (70%) had an abnormal ultrasound scan and the CT scan was abnormal in 9 out of 9 patients (100%). Seventy-three percent of the tumors were classified as anaplastic or poorly differentiated carcinoma and 27% as differentiated carcinoma. Complete surgical excision was performed in 8 cases and op'DDD was administered in 4 cases. The five-year survival rate was 30%. We can conclude that early diagnosis, staging and histopathology have a significant effect on survival and surgical excision is the only treatment associated with medium or long-term survival.

摘要

1973年至1991年期间,我院共诊断出13例肾上腺癌患者[4例女性(30%),9例男性(70%)]。诊断时的平均年龄为47.4岁(范围29至72岁)。11例患者(85%)出现腹部症状,8例(61%)出现副肿瘤综合征。诊断时,3例(23%)有临床或影像学转移征象。5例患者(38.5%)有区域受累,5例(38.5%)为局限性疾病。术前影像学检查显示,13例患者中有8例(61%)静脉肾盂造影异常;10例中有7例(70%)超声扫描异常,9例患者的CT扫描均异常(100%)。73%的肿瘤被分类为间变性或低分化癌,27%为高分化癌。8例患者接受了完整的手术切除,4例患者接受了双氯苯二氯乙烷治疗。五年生存率为30%。我们可以得出结论,早期诊断、分期和组织病理学对生存率有显著影响,手术切除是唯一与中长期生存相关的治疗方法。

相似文献

1
[Adrenal gland carcinoma. Clinical, pathologic, and therapeutic study].[肾上腺皮质癌。临床、病理及治疗研究]
Arch Esp Urol. 1994 Jul-Aug;47(6):557-62.
2
Real indications for adrenalectomy in renal cell carcinoma.肾细胞癌中肾上腺切除术的实际指征。
Scand J Urol Nephrol. 2002;36(4):273-7. doi: 10.1080/003655902320248236.
3
[Personal experience in diagnosis and localization of pheochromocytoma].[嗜铬细胞瘤诊断与定位的个人经验]
Srp Arh Celok Lek. 2002 Jul;130 Suppl 2:14-9.
4
The therapeutic value of adrenalectomy in case of solitary metastatic spread originating from primary renal cell cancer.肾上腺切除术对原发性肾细胞癌孤立性转移扩散病例的治疗价值。
Eur Urol. 2005 Aug;48(2):252-7. doi: 10.1016/j.eururo.2005.04.004. Epub 2005 Apr 21.
5
Adrenocortical tumors in children.儿童肾上腺皮质肿瘤
J Pediatr Surg. 2001 Apr;36(4):549-54. doi: 10.1053/jpsu.2001.22280.
6
A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.对11400例纯黏液性乳腺癌病例进行长期随访的回顾性研究。
Breast Cancer Res Treat. 2008 Oct;111(3):541-7. doi: 10.1007/s10549-007-9809-z. Epub 2007 Nov 18.
7
Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients.肾细胞癌肾上腺转移的外科治疗:45例患者的单中心经验
BJU Int. 2006 Mar;97(3):505-8. doi: 10.1111/j.1464-410X.2006.05934.x.
8
Pheochromocytoma in children.儿童嗜铬细胞瘤
J Pediatr Surg. 2001 Mar;36(3):447-52. doi: 10.1053/jpsu.2001.21612.
9
NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).1-氨基-2,4-二溴蒽醌(CAS编号:81-49-2)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学与致癌性研究(饲料喂养研究)
Natl Toxicol Program Tech Rep Ser. 1996 Aug;383:1-370.
10
NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).F344/N大鼠和B6C3F1小鼠经口给予邻苄基对氯苯酚(CAS编号:120-32-1)的NTP毒理学和致癌性研究(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 1994 Jan;424:1-304.